Real ChatGPT answer · index seedisb1T8gbXcwcompleteHealth and wellness · women's healthinformational
What are the absolute and relative contraindications for starting hormone replacement therapy using transdermal estradiol versus oral formulations?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What are the absolute and relative contraindications for starting hormone replacement therapy using transdermal estradiol versus oral formulations?
2 real searches · 1 real-search pass
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 2 queries…
Searches and sources
ChatGPT2 real searches · gpt-6
menopausal hormone therapy contraindications transdermal oral estrogen VTE guideline 2025 NAMS ACOG Endocrine Society Google ↗
ACOG hormone therapy contraindications history breast cancer stroke VTE liver disease unexplained vaginal bleeding transdermal estrogen Google ↗
- Treatment of the Symptoms of Menopause Guideline Resources · support.endocrine.org
- Full article: International Menopause Society (IMS) recommendations and key messages on women’s midlife health and menopause · doi.org
- ACOG Clinical Practice Guideline: Management of... : Obstetrics & Gynecology · doi.org
- Hormone therapy safety · womenshealth.gov
- Full article: International Menopause Society (IMS) recommendations and key messages on women’s midlife health and menopause · tandfonline.com
- These highlights do not include all the information needed to use ESTRADIOL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for ESTRADIOL TRANSDERMAL SYSTEM. ESTRADIOL transdermal system Initial U.S. Approval: 1996 · dailymed.nlm.nih.gov
Queries
2 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
menopausal hormone therapy contraindications transdermal oral estrogen VTE guideline 2025 NAMS ACOG Endocrine Society OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
ACOG hormone therapy contraindications history breast cancer stroke VTE liver disease unexplained vaginal bleeding transdermal estrogen OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |